IMBRIUM THERAPEUTICS Trademark

Trademark Overview

On Friday, June 14, 2019, a trademark application was filed for IMBRIUM THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the IMBRIUM THERAPEUTICS trademark a serial number of 88474325. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 16, 2023. This trademark is owned by Purdue Pharma L.P.. The IMBRIUM THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; analgesic preparations
imbrium therapeutics

General Information

Serial Number88474325
Word MarkIMBRIUM THERAPEUTICS
Filing DateFriday, June 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 15, 2019

Trademark Statements

Description of MarkThe mark consists of a series of seven parallel lines of different sizes, with the first four lines increasing in size to the fourth line and thereby decreasing in size from the fifth to the seventh lines, followed by a single vertical line next to the word "IMBRIUM" in large capital letters over the word "THERAPEUTICS" in small capital letters.
Goods and ServicesPharmaceutical preparations for the treatment of cancer; analgesic preparations
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePurdue Pharma L.P.
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressStamford, CT 06901
Party NamePurdue Pharma L.P.
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressStamford, CT 06901

Trademark Events

Event DateEvent Description
Tuesday, January 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 16, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 15, 2022SOU EXTENSION 5 GRANTED
Friday, June 3, 2022SOU EXTENSION 5 FILED
Friday, June 3, 2022TEAS EXTENSION RECEIVED
Thursday, December 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 7, 2021SOU EXTENSION 4 GRANTED
Tuesday, December 7, 2021SOU EXTENSION 4 FILED
Tuesday, December 7, 2021TEAS EXTENSION RECEIVED
Thursday, June 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 1, 2021SOU EXTENSION 3 GRANTED
Tuesday, June 1, 2021SOU EXTENSION 3 FILED
Tuesday, June 1, 2021TEAS EXTENSION RECEIVED
Friday, December 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 9, 2020SOU EXTENSION 2 GRANTED
Wednesday, December 9, 2020SOU EXTENSION 2 FILED
Wednesday, December 9, 2020TEAS EXTENSION RECEIVED
Thursday, May 7, 2020ASSIGNED TO EXAMINER
Tuesday, April 21, 2020CORRECTED NOA E-MAILED
Tuesday, April 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 20, 2020SOU EXTENSION 1 GRANTED
Monday, March 23, 2020SOU EXTENSION 1 FILED
Monday, April 20, 2020DIVISIONAL PROCESSING COMPLETE
Monday, March 23, 2020DIVISIONAL REQUEST RECEIVED
Thursday, April 16, 2020RESPONSE TO ITU OFFICE ACTION ENTERED
Thursday, April 16, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 15, 2020ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Wednesday, April 15, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 23, 2020TEAS EXTENSION RECEIVED
Monday, March 23, 2020TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 10, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 15, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 5, 2019ASSIGNED TO EXAMINER
Friday, June 28, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 18, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics imbrium preparations analgesic cancer treatment pharmaceutical